Endonovo Therapeutics, Inc. (OTCPK: ENDV)
Health Care · Biotechnology · US
$0.00
+100.00% today · 0.0% 1Y
Endonovo Therapeutics, Inc. (OTCPK: ENDV) operates in the Biotechnology industry within the Health Care sector. The company is valued at $180.76K and employs 1 people.
Over the last twelve months the share price has gained 0.0%, trading between 0.00 and 0.00.
Tweenvest scores Endonovo Therapeutics, Inc. across four factors: quality 13/100, value 51/100. Its strongest factor is value.
ENDV price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $180.76K
- Revenue (TTM)
- $255.72K
- P/E
- —
- EPS
- -0.06
- Dividend yield
- —
- Beta (5Y)
- 38.16
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 1.81B
- Employees
- 1
- Next earnings
- —
About Endonovo Therapeutics, Inc.
Endonovo Therapeutics, Inc., a biotechnology company, specializes in the development, manufacturing, and distribution of non-invasive electroceutical medical devices designed for regenerative medicine applications. The company's primary offering is SofPulse, an advanced non-invasive therapeutic device that employs electroceutical technology. SofPulse is engineered to provide palliative relief for various conditions, including soft tissue injuries, chronic wounds, and post-operative pain and edema. Beyond these applications, Endonovo's electroceutical medical device is also utilized in treating a broad spectrum of other ailments. These include inflammation, various types of wounds, cardiovascular diseases, chronic kidney and liver disorders (such as non-alcoholic steatohepatitis), peripheral artery diseases, and ischemic stroke. Furthermore, its technology is deployed in managing central nervous system disorders like traumatic brain injury, acute concussions, post-concussion syndrome, and multiple sclerosis. Endonovo Therapeutics, Inc. was founded in 2008 and maintains its headquarters in Woodland Hills, California.
- ISIN
- US29272H3003
- Founded
- 2008
- Listed since
- Nov 15, 2012
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| WPD Pharmaceuticals Inc.CNSX: WBIO | $233.63K | CA$— | — |
| Beroni Group LimitedOTCPK: BNIG.F | $216.88K | $— | — |
| NAVCO Pharmaceuticals Inc.TSXV: NAV | $200.86K | CA$0.01 | — |
| Ocean Biomedical, Inc.OTCPK: OCEA | $185.89K | $0.00 | +60.00% |
| Regen BioPharma, Inc.OTCPK: RGBP | $167.53K | $0.00 | -50.00% |
| Biosergen AB (publ)OM: BIOSGN | $142.46K | Skr0.50 | +3.77% |
| Oxurion NVENXTBR: OXUR | $126.66K | €0.00 | -33.33% |
| Many Bright Ideas Technologies Inc.TSXV: MBI.H | $120.88K | CA$0.01 | — |
Figures last refreshed Oct 18, 2026.